iBio, Inc. is focused on development and commercialization of novel plant-made products for the prevention and treatment of serious infectious diseases. To accelerate achievement of our objectives, we established a research & development relationship with a leading not-for-profit translational research institution, the Fraunhofer USA Center for Molecular Biotechnology (FhCMB). The success of this relationship has substantially reduced the risk of bringing important new medical products to market and has created a unique opportunity for investors.
In The News
July 26, 2017
Innovation Delaware Company to Watch: Prelude Therapeutics from a textbook or a lesson plan. “Discovery is an art,” Vaddi says. “It’s not something that’s taught.” As Vaddi’s latest business venture, Prelude Therapeutics, finds its way forward, he hopes to be …
February 22, 2017
The Delaware Small Business Development Center has prevented about 600 former DuPont workers from leaving Delaware to pursue jobs in other states, said J. Michael Bowman, the organization’s director. Bowman made the remarks Tuesday afternoon at a hearing before the …